TipRanks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
BDTX
Black Diamond Therapeutics
RESEARCH TOOLSreports
Want to see BDTX full AI Analyst Report?

Black Diamond Therapeutics (BDTX) Stock News & Sentiment

1,664 Followers
Black Diamond Therapeutics: Buy Rating Reiterated with Unchanged $11 Price Target on Clinical Catalysts and Strong Cash Runway
Premium
Ratings
Black Diamond Therapeutics: Buy Rating Reiterated with Unchanged $11 Price Target on Clinical Catalysts and Strong Cash Runway
3M ago
BDTX
Black Diamond Shareholders Approve Directors and Annual Say-on-Pay
Premium
Company Announcements
Black Diamond Shareholders Approve Directors and Annual Say-on-Pay
4M ago
8K
BDTX
Black Diamond Highlights Positive Phase 2 Silevertinib Lung Cancer Data
Premium
Company Announcements
Black Diamond Highlights Positive Phase 2 Silevertinib Lung Cancer Data
5M ago
8K
BDTX
Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028
Premium
Ratings
Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028
6M ago
BDTX
BDTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BDTX Upcoming Earnings Report: What to Expect?
8M ago
BDTX
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
Premium
Company Announcements
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
10M ago
BDTX
3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026
Premium
Market News
3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026
10M ago
BDTX
BTBT
More BDTX News >

BDTX News on the Web

Black Diamond Shareholders Approve Directors and Annual Say-on-Pay
TipRanks News
Neutral
Black Diamond Therapeutics Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)
TipRanks News
Bullish
Black Diamond Plunges Despite Positive Phase 2 Results For Silevertinib In 1L NSCLC
rttnews
Neutral
Black Diamond Highlights Positive Phase 2 Silevertinib Lung Cancer Data
TipRanks News
Bullish
Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 Study
MarketBeat
Bullish
SLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX
rttnews
Neutral

News Score - Last 7 Days

Neutral
BDTX
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BDTX’s Media Buzz Sentiment?
Currently, no data Available
What is BDTX’s weekly average amount of articles?
Currently, no data Available
What is BDTX’s News Sentiment?
100% of articles about BDTX were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    GKOSGlaukos
    CNCCentene
    ASNDAscendis Pharma
    GILDGilead Sciences
    MRKMerck & Company
    Showing the stocks with the most bullish news sentiment over the past week